Effect of Fingolimod on the Cardiac Autonomic Regulation in Patients With Multiple Sclerosis

Trial Profile

Effect of Fingolimod on the Cardiac Autonomic Regulation in Patients With Multiple Sclerosis

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 May 2014

At a glance

  • Drugs Fingolimod (Primary)
  • Indications Multiple sclerosis
  • Focus Pharmacodynamics
  • Acronyms FingoHRV
  • Most Recent Events

    • 22 Jan 2013 Planned End Date 1 Dec 2016 added as reported by ClinicalTrials.gov.
    • 31 Oct 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2012-002694-66)
    • 30 Oct 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top